Navigation Links
FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
Date:8/25/2011

tients may self-administer FIRAZYR.  Most patients respond to a single dose of FIRAZYR.  If response is inadequate or if symptoms recur, up to 2 additional doses may be administered within a 24 hour period at intervals of at least 6 hours.  

About HAE

HAE is a rare genetic disease caused by low levels or a dysfunction of C1 esterase inhibitor (C1-INH). Reduced C1-INH activity can lead to elevated plasma levels of bradykinin, which is thought to be responsible for HAE symptoms.

HAE is characterized by recurrent sudden attacks of edema (swelling) of the skin (hands, arms, feet, legs, thighs, face, genitals) or the mucous membranes (gastrointestinal tract, larynx or voicebox). The swelling can be disfiguring and painful, especially in case of abdominal attacks. Laryngeal attacks are potentially life-threatening due to the risk of suffocation. Unlike angioedema caused by allergic reactions, signs and symptoms such as hives and itching do not occur in HAE. Signs and symptoms of HAE do not respond to standard treatments for allergic angioedema such as epinephrine, corticosteroids, and antihistamines.

Summary of Clinical Trial Data Supporting the U.S. New Drug Application

The efficacy and safety of FIRAZYR for the treatment of acute attacks of HAE in adults were studied in three double-blind, randomized, controlled clinical trials known as FAST 1, 2 and 3. Among the 223 patients in these studies, the mean age was 38 years, 64% were female, and 95% were white.  Approximately 57% of patients reported use of attenuated androgens, antifibrinolytic agents, or C1 inhibitors.  

FAST 3 was a placebo-controlled study of 98 adult patients with a median age of 36 years. The primary endpoint was assessed using a 3-item composite visual analog score (VAS), comprised of averaged assessments of skin swelling, skin pain, and abdomi
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
2. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
3. FDA Approves Fougeras Clotrimazole Cream USP 1%
4. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
5. FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
6. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
7. FDA Approves Durameds LoSEASONIQUE(R) Oral Contraceptive
8. FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
9. FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
10. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
11. AUDIO from Medialink and GlaxoSmithKline: FDA Approves Boostrix for Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Veracyte, Inc. (NASDAQ: VCYT ... president and chief executive officer, will present at the ... 2015 at 10:30 a.m. ET in New ... audio webcast and subsequent replay may be accessed by ... available shortly after conclusion of the presentation and archived ...
(Date:9/2/2015)... ... 2015 , ... Advancing in medical imaging processing technology has ... in ICU to 3D skull printing analysis for Neurosurgery, ONYX ZEUS all-in-one surgical ... simultaneous access to high precision medical images and electronic health records. , ...
(Date:9/2/2015)... ... September 02, 2015 , ... Genedata, ... research, today unveiled Genedata Screener ® version 13.0 at ELRIG Drug Discovery ... to market a rich set of new capabilities. Screener now supports High Throughput ...
(Date:9/1/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... Annual Global Investment Conference sponsored by H.C. Wainwright ... The St. Regis Hotel in New York, ... , Chief Executive Officer, will provide an overview of ...
Breaking Biology Technology:Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... A group of business and technology leaders is asking ... pledged state funds for the Biomedical Technology Alliance ... researchers and private industry in southeastern Wisconsin. , ,The ... a margin of 15-1, and endorsed by the Doyle ...
... - ProHealth Care , a not-for-profit network ... application delivery system from NetScaler, Inc. , for ... to better coordinate application usage and response time across ... regional hospitals, 13 primary care clinics, home health care ...
... - Catalyst International, Inc., has appointed ... with more than 30 years of experience in the ... Data, where he last served as president of its ... America, Europe, Asia, India, Mexico and the Middle East. ...
Cached Biology Technology:Budget axe could cut SE Wisconsin tech alliance funding 2Budget axe could cut SE Wisconsin tech alliance funding 3
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
(Date:8/12/2015)... JOSE, Calif. , Aug. 12, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... recently announced Match-in-Sensor solution, have officially been named ... Alliance. As part of the certification, Synaptics, Natural ... FIDO 1.0 Universal Authentication Framework (UAF) standard and ...
(Date:8/10/2015)... LONDON , August 10, 2015 ... visiongain offers comprehensive analysis of the global border ... will generate revenues of $16.4bn in 2015. Now: ... This is an example of the business critical issue you ... to read visiongain ,s objective analysis of how this ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
... People and giant snakes not only target each other ... according to a study co-authored by a Cornell University researcher. ... modern Filipino hunter-gatherer group have been attacked by giant pythons ... their next meal. The study also finds that both the ...
... The Concord Consortium ( www.concord.org ) has received a ... for digital curricula that model the "textbook of tomorrow." ... but most examples out there still barely scratch the ... work creating better, deeply digital learning experiences for science, ...
... to provide a haven for both protected species and ... have analysed species living on the seabed (benthic species) ... areas require special protection., , "It,s not possible to ... That,s why I,ve done what experienced mushroom pickers do ...
Cached Biology News:The Concord Consortium awarded multi-million dollar Google grant 2Life on Kosterhavet's seabed analyzed 2
Mouse monoclonal antibody raised against a partial recombinant TPR. NCBI Entrez Gene ID = TPR...
... be used to test the crossreactivity of ... that are commonly used as blocking reagents ... for 19 different protein preparations on a ... and species specificity, QC of purified antibodies, ...
... Each kit contains sufficient materials for 1,464 array sample ... Membrane: 4 each , Blocker BSA in PBS ... mg , BupH Phosphate Buffered Saline: 8 packs ... , SuperSignal West Pico Luminol Enhancer: 2 x 25 ...
... Each kit contains sufficient materials for 1,464 array sample ... 4 each , Blocker BSA in ... Anti-Mouse Antibody, HRP-conjugated: 10 g , ... , 10% Tween-20: 2 x 10 ml ampules ...
Biology Products: